Scarica l'app Stockscreener
12.89
1.42%
0.18
Pre-mercato:
12.90
0.010
+0.08%
Precedente Chiudi:
$12.71
Aprire:
$12.69
Volume 24 ore:
3.70M
Relative Volume:
2.06
Capitalizzazione di mercato:
$877.57M
Reddito:
$2.73B
Utile/perdita netta:
$-1.13B
Rapporto P/E:
-0.7736
EPS:
-16.6622
Flusso di cassa netto:
$-83.00M
1 W Prestazione:
-19.84%
1M Prestazione:
-15.42%
6M Prestazione:
-55.55%
1 anno Prestazione:
-48.79%
Intervallo 1D:
$12.41
$13.36
Intervallo di 1 settimana:
$11.61
$18.00
Portata 52W:
$11.61
$38.99
Quidelortho Corp Stock (QDEL) Company Profile
Nome
Quidelortho Corp
Settore
Industria
Telefono
(858) 552-1100
Indirizzo
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Compare QDEL vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
QDEL
Quidelortho Corp
|
12.89 | 865.32M | 2.73B | -1.13B | -83.00M | -16.66 |
ABT
Abbott Laboratories
|
96.00 | 168.22B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
338.34 | 131.49B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
85.00 | 110.66B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
60.99 | 95.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.44 | 46.69B | 6.07B | 1.06B | 1.34B | 1.8063 |
Quidelortho Corp Stock (QDEL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-07 | Downgrade | Citigroup | Buy → Neutral |
| 2025-05-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-12-10 | Iniziato | Jefferies | Hold |
| 2024-09-19 | Ripresa | UBS | Neutral |
| 2024-09-05 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2024-03-04 | Downgrade | UBS | Neutral → Sell |
| 2024-02-14 | Downgrade | JP Morgan | Neutral → Underweight |
| 2023-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2022-12-12 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-14 | Aggiornamento | UBS | Sell → Neutral |
| 2022-09-19 | Iniziato | Citigroup | Neutral |
| 2022-07-20 | Iniziato | UBS | Sell |
| 2022-06-17 | Ripresa | JP Morgan | Neutral |
| 2022-02-22 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2021-01-22 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-05-12 | Downgrade | JP Morgan | Neutral → Underweight |
| 2020-03-26 | Downgrade | Barclays | Overweight → Equal Weight |
| 2018-10-23 | Ripresa | Raymond James | Strong Buy |
| 2018-03-08 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2018-01-22 | Reiterato | Barclays | Overweight |
| 2018-01-04 | Aggiornamento | CL King | Neutral → Buy |
| 2017-09-19 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2017-07-18 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2017-07-18 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2017-04-25 | Reiterato | Canaccord Genuity | Hold |
| 2017-02-17 | Iniziato | CL King | Neutral |
| 2016-12-16 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2016-06-13 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2016-02-18 | Reiterato | Barclays | Overweight |
| 2016-02-09 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2016-01-08 | Reiterato | Canaccord Genuity | Buy |
| 2015-12-14 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2015-09-02 | Iniziato | Barclays | Overweight |
| 2013-07-31 | Reiterato | Canaccord Genuity | Buy |
| 2011-03-03 | Downgrade | Wedbush | Outperform → Neutral |
Mostra tutto
Quidelortho Corp Borsa (QDEL) Ultime notizie
QuidelOrtho completes LEX Diagnostics buy for $100 million By Investing.com - Investing.com India
QuidelOrtho Corp. Hits Day Low of $11.63 Amid Price Pressure - Markets Mojo
QuidelOrtho acquires molecular diagnostics firm LEX Diagnostics By Investing.com - Investing.com Australia
QuidelOrtho Corp. Opens with 5.51% Gain Amid Ongoing Financial Challenges - Markets Mojo
QuidelOrtho (QDEL) Completes $100M Acquisition of LEX Diagnostics - GuruFocus
TTP Group announces sale of LEX Diagnostics to QuidelOrtho - TipRanks
QuidelOrtho (QDEL) Acquires LEX Diagnostics for Rapid Testing In - GuruFocus
QuidelOrtho Completes $100 Million Acquisition of LEX Diagnostics to Expand Rapid Molecular Testing - citybiz
QuidelOrtho: $100 Million Acquisition Of LEX Diagnostics Completed To Expand Ultra-Fast PCR Testing - Pulse 2.0
QuidelOrtho Completes Acquisition of LEX Diagnostics and Molecular Testing Platform - Clinical Lab Products
PCR results in 6 minutes: QuidelOrtho buys LEX Diagnostics - Stock Titan
QuidelOrtho completes LEX Diagnostics buy for $100 million - Investing.com
10-minute flu and COVID PCR test joins QuidelOrtho in $100M deal - Stock Titan
QuidelOrtho, MIND Technology, Southern First Bancshares and other big stocks moving lower in Thursday's pre-market session - MSN
QuidelOrtho stock sinks to 52-week lowhere's why - MSN
QuidelOrtho Corp. Hits Day High with Strong 8.6% Intraday Surge - Markets Mojo
QuidelOrtho Corp. Faces Weak Start with 13.49% Gap Down Amid Market Concerns - Markets Mojo
QuidelOrtho Corp. Stock Plummets to New 52-Week Low at $14.00 - Markets Mojo
QuidelOrtho Looks Mispriced If 2026's FCF Turnaround Materializes (NASDAQ:QDEL) - Seeking Alpha
QuidelOrtho preliminary revenue to hit USD 615-620M in Q1 2026 - Medical Buyer
QuidelOrtho (QDEL) drops 20% after-hours on Wednesday—what's going on? - MSN
QuidelOrtho Corp. Stock Plummets to New 52-Week Low of $11.63 - Markets Mojo
J.P. Morgan Maintains QuidelOrtho(QDEL.US) With Sell Rating, Cuts Target Price to $15 - Moomoo
QuidelOrtho, MIND Technology, Southern First Bancshares And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Sahm
QuidelOrtho Corp (QDEL) Stock Down 27.5% -- Now Undervalued? GF Score: 61/100 - GuruFocus
QuidelOrtho (QDEL) Valuation Check After Weaker Q1 2026 Revenue Guidance And Sharply Negative Share Returns - simplywall.st
Why These Medical Plays Just Diverged; One Eyes A Breakout - Investor's Business Daily
This Diagnostics Stock Is Sinking 27%. Why the Moderate Flu Season Was Bad for Business. - Barron's
UBS reiterates Quidel stock rating at Neutral on weak Q1 results - Investing.com UK
QuidelOrtho (NASDAQ:QDEL) Sets New 1-Year LowHere's What Happened - MarketBeat
UBS reiterates Quidel stock rating at Neutral on weak Q1 results By Investing.com - Investing.com South Africa
William Blair Maintains QuidelOrtho(QDEL.US) With Hold Rating - Moomoo
QuidelOrtho, MIND Technology, Southern First Bancshares And Other Big Stocks Moving Lower In Thursday's P - Benzinga
QuidelOrtho eyes revenue of USD 615-620M in Q1 2026 - Medical Buyer
QuidelOrtho Shares Slide on Expected Sales Dent From Macro Pressures - Moomoo
QuidelOrtho Shares Plunge 20% After Weak Q1 Outlook - National Today
QuidelOrtho Announces Preliminary Q1 2026 Revenue, Updates Full-Year Guidance - National Today
QuidelOrtho (QDEL) Drops 20% After-Hours On Wednesday— What's Going On? - Benzinga
QuidelOrtho (QDEL) Projects Lower Q1 2026 Revenue Amid Weaker De - GuruFocus
QuidelOrtho (QDEL) Sees 12% Drop Following Disappointing Q1 Reve - GuruFocus
QuidelOrtho announces preliminary revenue for the first quarter 2026 and provides update on full-year 2026 guidance - marketscreener.com
Quidelortho Announces Preliminary Revenue For The First Quarter 2026 And Provides Update On Full-Year 2026 Guidance - TradingView
QuidelOrtho announces preliminary revenue for the first quarter of 2026 and updates its full-year 2026 performance outlook. - 富途牛牛
QuidelOrtho stock plunges on weak revenue guidance - Investing.com
QuidelOrtho (QDEL) Projects Q1 2026 Revenue Impacted by Market C - GuruFocus
QuidelOrtho Expects Q1 Revenue of $615 Million-$620 Million; Shares Fall After Hours - marketscreener.com
Quidelortho Corp Azioni (QDEL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.74%
1.72%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):